DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

20 Microns Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 5 hrs ago·6 Oct 2026, 11:38 am

20 Microns

20 Microns Limited has recently informed stock exchanges that it has obtained a Certificate under SEBI (Depositories and Participants) Regulations, 2018. This document confirms that the company is fully compliant with the regulatory framework governing securities depositories and their participants.

For investors, this development is largely procedural. It signifies that the company has met the necessary legal requirements for its dealings with depositories, ensuring a clean regulatory status. While it does not directly impact the company's financial performance, it reinforces the firm's adherence to corporate governance norms.

Investors should monitor the company's future announcements for any updates on compliance or other regulatory matters. This certificate serves as a baseline indicator of the company's regulatory health but does not, by itself, signal any immediate change in business operations or stock performance.